Synapse Open Synapse
Biology

This week in charts: Moderna’s massive stock run

BioPharma Dive · · 2 min read

The latest installment in BioPharma Dive’s data visualization-focused series includes a look at Moderna’s meteoric rise in 2026 and a sudden deal surge from Roche.

Latest from BioPharma Dive